Biofilms Treatment Market for Gauzes and Dressings Segment to Grow Significantly during 2020–2027
According to the latest study on “Biofilms Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Wound Type, and End User,” the market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027. The report highlights trends prevailing in the global biofilms treatment market, and the factors driving and restraining the market growth.
Biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it, and viscous and shiny substances with unpleasant smell are secreted. The growing number of traumatic and sports injuries, and increasing prevalence of obesity are anticipated to drive the market growth during the forecast period.
Based on product, the global biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and other products. The gauzes and dressings segment held the largest share of the market in 2019, and it is expected to retain its dominance during the forecast period.
Mimedx Group Inc., Convatec Group Plc, Coloplast A/S, Mölnlycke Healthcare AB, Organogenesis Holdings Inc., Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, Paul Hartmann AG, Medline Industries Inc, and Smith and Nephew Plc are among the companies operating in the biofilms treatment market.
By Product
By Wound Type
By End User
By Geography
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com